1 followers
RT @FrontMedicine: New Research: Are Patients at Risk for Recurrent Disease Activity After Switching From Remicade® to Remsima®? An Observa…
RT @FrontMedicine: New Research: Are Patients at Risk for Recurrent Disease Activity After Switching From Remicade® to Remsima®? An Observa…
New Research: Are Patients at Risk for Recurrent Disease Activity After Switching From Remicade® to Remsima®? An Observational Study: Background: Since the late ‘90s, infliximab (Remicade®) is being used successfully to… https://t.co/3NcZl4fhGa #medicalcar
Congratulations Willem on your newly published @FrontiersIn article: https://t.co/K3RNWnu0e1